|
Main Concepts
risk pts, shcs pts, ct, cd4, diagnosis, anti-toxoplasma antibodies, toxoplasmic infection, latent toxoplasmic infection, swiss hiv cohort study
|
|
Summary
(
Short,
Extended
)
|
|
|
|
METHODS: Since 1.12.90, all SHCS pts have been screened for anti-toxoplasma antibodies. CT was diagnosed in 12% (126/1018) of toxo+ pts. They represented 33% (126/385) of at risk pts (i.e. those with anti-toxoplasma IgG antibodies and CD4 cells less than 250/microliters). IgG titers increased in 22% of pts with CT as compared with 8% of pts without CT (p = 0.001). Repeated determination of IgG may be of interest in pts at risk for CT
METHODS: Since 1.12.90, all SHCS pts have been screened for anti-toxoplasma antibodies.
CT was diagnosed in 12% (126/1018) of toxo+ pts.
They represented 33% (126/385) of at risk pts (i.e. those with anti-toxoplasma IgG antibodies and CD4 cells less than 250/microliters).
IgG titers increased in 22% of pts with CT as compared with 8% of pts without CT (p = 0.001).
Repeated determination of IgG may be of interest in pts at risk for CT
|
|
|